AMAG Pharmaceuticals announced it is selling Cord Blood Registry (CBR), the largest private cord blood bank in the U.S., to GI Partners for a price tag of $530 million. This is $170 million less than AMAG Pharmaceuticals paid to acquire CBR as an asset in mid-2015, three years ago.
GI Partners, a private equity investment firm, is simultaneously acquiring CBR and California Cryobank (CCB), world’s premier donor sperm and egg bank, to merge the companies into a single entity that will be the global leader in stem cell storage and reproductive tissue services. [Read more…]